The ERK1/2-Elk1, JNK-cJun, and JAK-STAT Transcriptional Axes as Potential Bortezomib Resistance Mediators in Prostate Cancer
G. Kalampounias, K. Zafeiropoulou, T. Androutsopoulou, S. Alexis, A. Symeonidis, P. Katsoris
This study identifies upregulated transcription factors in Bortezomib-resistant prostate cancer cells and suggests targeting them to restore sensitivity to proteasome inhibitors.
bioRxiv · Apr 15, 2024Cancer Biology